Trial Site Detail

 

Drug:
Dovitinib
Trial:
Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib (DoviGIST)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Site name unknown - Lyon

     
Lyon , 69373
France

 

Principal Investigator:
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Site name unknown - Lyon Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.